JP2001516216A - 非相同ｄｎａ配列のシャッフリング - Google Patents
非相同ｄｎａ配列のシャッフリングInfo
- Publication number
- JP2001516216A JP2001516216A JP54004498A JP54004498A JP2001516216A JP 2001516216 A JP2001516216 A JP 2001516216A JP 54004498 A JP54004498 A JP 54004498A JP 54004498 A JP54004498 A JP 54004498A JP 2001516216 A JP2001516216 A JP 2001516216A
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- pcr
- region
- conserved
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091028043 Nucleic acid sequence Proteins 0.000 title claims description 53
- 239000012634 fragment Substances 0.000 claims abstract description 70
- 238000000034 method Methods 0.000 claims abstract description 62
- 108091005804 Peptidases Proteins 0.000 claims abstract description 17
- 238000012216 screening Methods 0.000 claims abstract description 17
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims abstract description 16
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims abstract description 16
- 230000004071 biological effect Effects 0.000 claims abstract description 14
- 239000004365 Protease Substances 0.000 claims abstract description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 37
- 238000006243 chemical reaction Methods 0.000 claims description 26
- 108020004414 DNA Proteins 0.000 claims description 22
- 102000004169 proteins and genes Human genes 0.000 claims description 22
- 108090001060 Lipase Proteins 0.000 claims description 16
- 230000000694 effects Effects 0.000 claims description 15
- 102000004882 Lipase Human genes 0.000 claims description 14
- 239000004367 Lipase Substances 0.000 claims description 14
- 235000019421 lipase Nutrition 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 108091081021 Sense strand Proteins 0.000 claims description 12
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 9
- 230000000692 anti-sense effect Effects 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 238000005215 recombination Methods 0.000 claims description 8
- 230000006798 recombination Effects 0.000 claims description 8
- 238000012408 PCR amplification Methods 0.000 claims description 7
- 108010022999 Serine Proteases Proteins 0.000 claims description 6
- 102000012479 Serine Proteases Human genes 0.000 claims description 6
- 239000003599 detergent Substances 0.000 claims description 5
- 238000004851 dishwashing Methods 0.000 claims description 4
- 238000007857 nested PCR Methods 0.000 claims description 4
- 238000003491 array Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000002703 mutagenesis Methods 0.000 claims description 2
- 231100000350 mutagenesis Toxicity 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 108010034272 tyrase Proteins 0.000 claims 1
- 102000035195 Peptidases Human genes 0.000 abstract description 4
- 108091033319 polynucleotide Proteins 0.000 abstract description 4
- 102000040430 polynucleotide Human genes 0.000 abstract description 4
- 239000002157 polynucleotide Substances 0.000 abstract description 4
- 230000001747 exhibiting effect Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 229940088598 enzyme Drugs 0.000 description 10
- 238000009396 hybridization Methods 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- 101710135785 Subtilisin-like protease Proteins 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000000499 gel Substances 0.000 description 7
- 241000589516 Pseudomonas Species 0.000 description 5
- 238000004590 computer program Methods 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 239000013605 shuttle vector Substances 0.000 description 3
- 241000235389 Absidia Species 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241001302160 Escherichia coli str. K-12 substr. DH10B Species 0.000 description 2
- 241000208474 Protea Species 0.000 description 2
- 101710130181 Protochlorophyllide reductase A, chloroplastic Proteins 0.000 description 2
- 108010019653 Pwo polymerase Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000223258 Thermomyces lanuginosus Species 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 238000002741 site-directed mutagenesis Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 108010011619 6-Phytase Proteins 0.000 description 1
- 241001375492 Absidia reflexa Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 240000003966 Chrysopogon subtilis Species 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 241000223198 Humicola Species 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 102100038946 Proprotein convertase subtilisin/kexin type 6 Human genes 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000589538 Pseudomonas fragi Species 0.000 description 1
- 241000589630 Pseudomonas pseudoalcaligenes Species 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 241000577556 Pseudomonas wisconsinensis Species 0.000 description 1
- 241000235403 Rhizomucor miehei Species 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 108700037663 Subtilisin-like proteases Proteins 0.000 description 1
- 108010056079 Subtilisins Proteins 0.000 description 1
- 102000005158 Subtilisins Human genes 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- MUCZHBLJLSDCSD-UHFFFAOYSA-N diisopropyl fluorophosphate Chemical compound CC(C)OP(F)(=O)OC(C)C MUCZHBLJLSDCSD-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 108010030074 endodeoxyribonuclease MluI Proteins 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229960005051 fluostigmine Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- -1 is t al. Proteins 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 108010020132 microbial serine proteinases Proteins 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229940085127 phytase Drugs 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
- C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK0304/97 | 1997-03-18 | ||
| DK30497 | 1997-03-18 | ||
| DK0432/97 | 1997-04-17 | ||
| DK43297 | 1997-04-17 | ||
| PCT/DK1998/000105 WO1998041623A1 (en) | 1997-03-18 | 1998-03-18 | Shuffling of heterologous dna sequences |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001516216A true JP2001516216A (ja) | 2001-09-25 |
| JP2001516216A5 JP2001516216A5 (enExample) | 2005-11-10 |
Family
ID=26063733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54004498A Pending JP2001516216A (ja) | 1997-03-18 | 1998-03-18 | 非相同ｄｎａ配列のシャッフリング |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1015575B1 (enExample) |
| JP (1) | JP2001516216A (enExample) |
| AT (1) | ATE468394T1 (enExample) |
| AU (1) | AU738461B2 (enExample) |
| CA (1) | CA2284097A1 (enExample) |
| DE (1) | DE69841674D1 (enExample) |
| DK (1) | DK1015575T3 (enExample) |
| IL (1) | IL131986A0 (enExample) |
| NZ (1) | NZ337910A (enExample) |
| WO (1) | WO1998041623A1 (enExample) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6995017B1 (en) | 1994-02-17 | 2006-02-07 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6309883B1 (en) | 1994-02-17 | 2001-10-30 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US20060257890A1 (en) | 1996-05-20 | 2006-11-16 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US6936289B2 (en) | 1995-06-07 | 2005-08-30 | Danisco A/S | Method of improving the properties of a flour dough, a flour dough improving composition and improved food products |
| US6326204B1 (en) | 1997-01-17 | 2001-12-04 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
| US7148054B2 (en) | 1997-01-17 | 2006-12-12 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
| US6153410A (en) * | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
| DE1193314T1 (de) | 1997-04-09 | 2002-10-02 | Danisco A/S, Copenhagen | Lipase und Verwendung davon zur Verbesserung von Teigen und Backwaren |
| WO1999029902A1 (en) | 1997-12-08 | 1999-06-17 | California Institute Of Technology | Method for creating polynucleotide and polypeptide sequences |
| US7390619B1 (en) | 1998-02-11 | 2008-06-24 | Maxygen, Inc. | Optimization of immunomodulatory properties of genetic vaccines |
| CA2325567A1 (en) | 1998-05-01 | 1999-11-11 | Maxygen, Inc. | Optimization of pest resistance genes using dna shuffling |
| US7153655B2 (en) | 1998-06-16 | 2006-12-26 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence |
| US6846655B1 (en) | 1998-06-29 | 2005-01-25 | Phylos, Inc. | Methods for generating highly diverse libraries |
| WO2000009682A1 (en) | 1998-08-12 | 2000-02-24 | Maxygen, Inc. | Dna shuffling of monooxygenase genes for production of industrial chemicals |
| WO2000020573A2 (en) | 1998-10-07 | 2000-04-13 | Maxygen, Inc. | Dna shuffling to produce nucleic acids for mycotoxin detoxification |
| EP1129184A1 (en) | 1998-11-10 | 2001-09-05 | Maxygen, Inc. | Modified adp-glucose pyrophosphorylase for improvement and optimation of plant phenotypes |
| US6917882B2 (en) | 1999-01-19 | 2005-07-12 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| WO2000042560A2 (en) | 1999-01-19 | 2000-07-20 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides |
| US6436675B1 (en) | 1999-09-28 | 2002-08-20 | Maxygen, Inc. | Use of codon-varied oligonucleotide synthesis for synthetic shuffling |
| US6961664B2 (en) | 1999-01-19 | 2005-11-01 | Maxygen | Methods of populating data structures for use in evolutionary simulations |
| US7024312B1 (en) | 1999-01-19 | 2006-04-04 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| IL144657A0 (en) | 1999-02-11 | 2002-06-30 | Maxygen Inc | High throughput mass spectrometry |
| US6531316B1 (en) | 1999-03-05 | 2003-03-11 | Maxyag, Inc. | Encryption of traits using split gene sequences and engineered genetic elements |
| AU4456200A (en) * | 1999-04-13 | 2000-11-14 | Maxygen, Inc. | Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes |
| US7430477B2 (en) | 1999-10-12 | 2008-09-30 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
| US6686515B1 (en) | 1999-11-23 | 2004-02-03 | Maxygen, Inc. | Homologous recombination in plants |
| US7115712B1 (en) | 1999-12-02 | 2006-10-03 | Maxygen, Inc. | Cytokine polypeptides |
| IL150291A0 (en) | 2000-01-11 | 2002-12-01 | Maxygen Inc | Integrated systems and methods for diversity generation and screening |
| US6248541B1 (en) | 2000-04-21 | 2001-06-19 | Genencor International, Inc. | Screening under nutrient limited conditions |
| US6534292B1 (en) | 2000-05-08 | 2003-03-18 | Genencor International, Inc. | Methods for forming recombined nucleic acids |
| US20020045175A1 (en) * | 2000-05-23 | 2002-04-18 | Zhen-Gang Wang | Gene recombination and hybrid protein development |
| AU2001268716A1 (en) | 2000-06-23 | 2002-01-08 | Maxygen, Inc. | Novel chimeric promoters |
| AU2001272978A1 (en) | 2000-06-23 | 2002-01-08 | Maxygen, Inc. | Novel co-stimulatory molecules |
| EP2281878A1 (en) | 2000-06-26 | 2011-02-09 | Novozymes A/S | Lipolytic enzyme |
| US6994963B1 (en) | 2000-07-10 | 2006-02-07 | Ambion, Inc. | Methods for recombinatorial nucleic acid synthesis |
| US6858422B2 (en) | 2000-07-13 | 2005-02-22 | Codexis, Inc. | Lipase genes |
| AUPQ974900A0 (en) * | 2000-08-29 | 2000-09-21 | Macquarie Research Limited | Degenerate oligonucleotide gene-shuffling |
| US6582914B1 (en) | 2000-10-26 | 2003-06-24 | Genencor International, Inc. | Method for generating a library of oligonucleotides comprising a controlled distribution of mutations |
| US6958213B2 (en) | 2000-12-12 | 2005-10-25 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function |
| DE60220155T2 (de) | 2001-05-18 | 2008-02-07 | Danisco A/S | Verfahren zur herstellung von teig mit einem enzym |
| DK1421224T3 (da) | 2001-06-26 | 2013-01-21 | Novozymes As | Polypeptider med cellobiohydrolase I aktivitet og polynukleotider der koder for samme |
| EP1409667B2 (en) | 2001-07-23 | 2009-06-10 | DSM IP Assets B.V. | Process for preparing variant polynucleotides |
| DK1504098T4 (da) | 2002-05-17 | 2011-05-23 | Alligator Bioscience Ab | Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion |
| CN1729287A (zh) | 2002-12-20 | 2006-02-01 | 诺维信公司 | 具有纤维二糖水解酶ⅱ活性的多肽及编码它的多核苷酸 |
| ES2534903T3 (es) | 2002-12-20 | 2015-04-30 | Novozymes A/S | Variantes de galactanasas |
| MXPA05007653A (es) | 2003-01-17 | 2005-09-30 | Danisco | Metodo. |
| EP2228440B1 (en) | 2003-05-02 | 2012-08-22 | Novozymes Inc. | Variants of beta-glucosidases |
| CN103088001A (zh) | 2003-08-25 | 2013-05-08 | 诺维信股份有限公司 | 糖苷水解酶的变体 |
| JP2007509603A (ja) | 2003-10-10 | 2007-04-19 | ノボザイムス アクティーゼルスカブ | プロテアーゼ変異型 |
| WO2005080559A1 (en) | 2004-02-25 | 2005-09-01 | Novozymes A/S | Fungall cell wall degrading enzyme |
| GB0405637D0 (en) | 2004-03-12 | 2004-04-21 | Danisco | Protein |
| DK1766040T3 (da) | 2004-05-27 | 2017-11-13 | Novozymes Inc | Fremgangsmåder til transformering og ekspressions-screening af filamentøse svampeceller med et DNA-bibliotek |
| EP2267107A3 (en) | 2004-07-16 | 2011-05-25 | Danisco A/S | Lipolytic Enzyme. Uses Thereof In The Food Industry |
| WO2016164583A2 (en) | 2015-04-07 | 2016-10-13 | Novozymes A/S | Methods for selecting enzymes having enhanced activity |
| CN107864658A (zh) | 2015-04-07 | 2018-03-30 | 诺维信公司 | 用于选择具有脂肪酶活性的酶的方法 |
| CN109312333A (zh) | 2016-04-07 | 2019-02-05 | 诺维信公司 | 选择具有蛋白酶活性的酶的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
-
1998
- 1998-03-18 NZ NZ337910A patent/NZ337910A/en unknown
- 1998-03-18 DE DE69841674T patent/DE69841674D1/de not_active Expired - Lifetime
- 1998-03-18 CA CA002284097A patent/CA2284097A1/en not_active Abandoned
- 1998-03-18 WO PCT/DK1998/000105 patent/WO1998041623A1/en not_active Ceased
- 1998-03-18 AT AT98907912T patent/ATE468394T1/de not_active IP Right Cessation
- 1998-03-18 IL IL13198698A patent/IL131986A0/xx unknown
- 1998-03-18 EP EP98907912A patent/EP1015575B1/en not_active Revoked
- 1998-03-18 JP JP54004498A patent/JP2001516216A/ja active Pending
- 1998-03-18 DK DK98907912.4T patent/DK1015575T3/da active
- 1998-03-18 AU AU66116/98A patent/AU738461B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69841674D1 (de) | 2010-07-01 |
| EP1015575A1 (en) | 2000-07-05 |
| AU738461B2 (en) | 2001-09-20 |
| EP1015575B1 (en) | 2010-05-19 |
| ATE468394T1 (de) | 2010-06-15 |
| CA2284097A1 (en) | 1998-09-24 |
| NZ337910A (en) | 2001-10-26 |
| AU6611698A (en) | 1998-10-12 |
| IL131986A0 (en) | 2001-03-19 |
| DK1015575T3 (da) | 2010-08-23 |
| WO1998041623A1 (en) | 1998-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001516216A (ja) | 非相同ｄｎａ配列のシャッフリング | |
| JP4263248B2 (ja) | Ｄｎａのシャッフリングによるライブラリーの作成方法 | |
| US6368805B1 (en) | Methods of producing polynucleotide variants | |
| EP0583339B1 (en) | Stabilized enzymes and detergent compositions | |
| EP0516200B1 (en) | Detergent compositions containing stabilized enzymes | |
| US5756316A (en) | Molecular cloning by multimerization of plasmids | |
| US7098017B2 (en) | Protease variants and compositions | |
| JP2002533080A (ja) | 活性部位ループ領域中に追加のアミノ酸残基を有するサブチラーゼ酵素サブグループｉ−ｓ１及びｉ−ｓ２ | |
| JP2002508926A (ja) | プロテアーゼ変異体及び組成物 | |
| JP2002533066A (ja) | 活性部位ループ領域中に追加のアミノ酸残基を有するサブチラーゼ酵素サブグループｉ−ｓ１及びｉ−ｓ２ | |
| UA73940C2 (uk) | Спосіб одержання біологічно активної молекули | |
| US6291165B1 (en) | Shuffling of heterologous DNA sequences | |
| JP2002533074A (ja) | 活性部位ループ領域中に追加のアミノ酸残基を有するサブチラーゼ酵素サブグループｉ−ｓ１及びｉ−ｓ２ | |
| CN100415880C (zh) | 在97与98位之间具有至少一个额外氨基酸残基的i-s1和i-s2亚组枯草杆菌酶 | |
| JP2002533075A (ja) | 活性部位ループ領域中に追加のアミノ酸残基を有するサブチラーゼ酵素サブグループｉ−ｓ１及びｉ−ｓ２ | |
| MXPA99008622A (en) | Shuffling of heterologous dna sequences | |
| JP2002533076A (ja) | 活性部位ループ領域中に追加のアミノ酸残基を有するサブチラーゼ酵素サブグループｉ−ｓ１及びｉ−ｓ２ | |
| JP2002533078A (ja) | 活性部位ループ領域中に追加のアミノ酸残基を有するサブチラーゼ酵素サブグループｉ−ｓ１及びｉ−ｓ２ | |
| JP4050654B6 (ja) | 安定化酵素及び洗剤 | |
| JP2002533077A (ja) | 活性部位ループ領域中に追加のアミノ酸残基を有するサブチラーゼ酵素サブグループｉ−ｓ１及びｉ−ｓ２ | |
| JP2002533079A (ja) | 活性部位ループ領域中に追加のアミノ酸残基を有するサブチラーゼ酵素サブグループｉ−ｓ１及びｉ−ｓ２ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050318 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050318 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20050318 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070925 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071221 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080204 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080325 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090804 |